Table 1 Characteristics of the study population, study outcomes and type of procedure
KetoDex group | DexMid group | ||
|---|---|---|---|
n = 40 | n = 40 | p | |
Characteristics of the study population | |||
Gender male, n (%) | 24 (60.0%) | 18 (45.0%) | 0.18 |
Weight (Kg), median (IQR) | 12.5 (11.0–17.0) | 14.9 (11.5–18.0) | 0.29 |
Age (months), median (IQR) | 29.5 (20.0–49.5) | 45.5 (31.5–56.5) | 0.05 |
0–1 years (%) | 2 (5%) | 7 (17.5%) | |
1–2 years (%) | 12 (30%) | 1 (2.5%) | |
2–3 years (%) | 12 (30%) | 4 (10%) | |
3–4 years (%) | 4 (10%) | 12 (30%) | |
4–5 years (%) | 5 (12.5%) | 7 (17.5%) | |
5–6 years (%) | 1 (2.5%) | 4 (10%) | |
6–7 years (%) | 1 (2.5%) | 3 (7.5%) | |
7–8 years (%) | 1 (2.5%) | 0 | |
9–10 years (%) | 1 (2.5%) | 0 | |
10–11 years (%) | 1 (2.5%) | 0 | |
11–12 years (%) | 0 | 1 (2.5%) | |
14–15 years (%) | 0 | 1 (2.5%) | |
Comorbidities | 5 (2 tonsillar hyprtrophy grade III, 1 NF1, 1 macrocephaly, 1 prematurity with bronchial dysplasia) | ||
Study outcomes | |||
Procedures’ success rate (%) | 31 (78.5%) | 33 (82.5%) | OR 0,73 (0.24–2.2) |
Induction time (minutes), median (IQR) | 13.5 (10.0–20.0) | 35.0 (21.3–44.5) | < 0.001 |
Recovery time (minutes), median (IQR) | 72.5 (60.3–103.0) | 71.5 (53.0–90.8) | 0.32 |
Need for rescue sedative, n (%) | 9 (22.5%) | 7 (17.5%) | 0.58 |
Adverse events, n (%) | 2 (5.0%) | 4 (10.0%) | 0.68 |
Type of Adverse events (%)a | Vomiting (50%), self resolving desaturation (50%) | Self resolving desaturations (100%) | |
Type of procedure | |||
Magnetic Resonance Imaging | 28 (70%) | 40 (100%) | NA |
Renal Scintigraphy | 4 (10%) | 0 (0%) | NA |
Computer Tomography | 3 (7,5%) | 0 (0%) | NA |
Electroencephalography | 1 (2,5%) | 0 (0%) | NA |
Echocardiography | 2 (5%) | 0 (0%) | NA |
Auditory Brainstem Response | 2 (5%) | 0 (0%) | NA |